Status | Study |
RECRUITING |
Study Name: US Selumetinib Registry Condition: Neurofibromatosis Type 1 Date: 2023-01-05 |
Recruiting |
Study Name: Efficacy of Computerized Cognitive Training and Stimulant Medication in Neurofibromatosis Type 1 Condition: Neurofibromatosis Type 1 Date: 2016-05-25 Interventions: Other: CogmedRM Cogmed RM is a |
Enrolling by invitation |
Study Name: Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1 Condition: Neurofibromatosis 1 Date: 2016-01-15 Interventions: Other: Blood sample 10 mL venous blood sample for analysis of plasma |
Recruiting |
Study Name: Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma Condition: Neurofibromatosis Type 1 Date: 2015-10-20 Interventions: Device: Magnetic resonance imaging |
Not yet recruiting |
Study Name: Subtle Myocardial Deformation Abnormalities in Asymptomatic Nf-1 Patients Condition: Neurofibromatosis Type 1 Date: 2015-07-16 |
Completed |
Study Name: Functional Imaging and Reading Deficit in Children With NF1 Condition: Neurofibromatosis Type 1 Date: 2015-03-27 Interventions: Other: Neuropsychological assessments |
Completed |
Study Name: Reading Disability in Children With NF1 Condition: Neurofibromatosis Type 1 Date: 2015-03-13 Interventions: Other: Neuropsychological assessments Neuropsychological a |
Recruiting |
Study Name: Effect of Lamotrigine on Cognition in NF1 Condition: Neurofibromatosis Type 1 Date: 2014-09-17 Interventions: Drug: Lamotrigine Other Name: |
Recruiting |
Study Name: Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1. Condition: Neurofibromatosis Type 1 Date: 2014-02-26 |
Not yet recruiting |
Study Name: Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1) Condition: Neurofibromatosis Type 1 (NF1) Date: 2013-10-07 Interventions: Drug: Cholecalciferol A pharmacist employed by DDrops(trademark) prepares two sets of bottles, one set h |